Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Advanced Medicine

Business & Regulation Advanced Medicine

Rewriting the Rulebook

| James Strachan

Sitting Down With… Frédéric Triebel, Co-Founder, Chief Scientific Officer, and Chief Medical Officer of Immutep, France.

Discovery & Development Drug Discovery

Better Use Case

| Maryam Mahdi

Researchers are investigating the therapeutic value of immunotherapies for treating infectious diseases.

Discovery & Development Drug Discovery

Alleviating the Pressure

| Maryam Mahdi

A gene therapy could help prevent the symptoms of glaucoma.

Discovery & Development Drug Discovery

Stronger Together

| Maryam Mahdi

A repurposed drug could help improve immunotherapy response rates.

Manufacture Advanced Medicine

Viral Vectors in Vogue

| Arvind Srivastava

We must collaborate to address stability challenges in viral vector manufacturing.

Manufacture Advanced Medicine

Peeking into the CGT Pipeline

| James Strachan

Intel shows a rise in cell and gene therapy development in the US, with China not far behind.

Manufacture Advanced Medicine

Advanced Medicine in Brief

| James Strachan

Tackling solid tumors with macrophages, a stem cell cure for HIV, and travel bans… What’s new in advanced medicine?

Manufacture Advanced Medicine

Hot Topics at CAR-TCR 2020

| James Strachan

In what may have been one of the last advanced therapy meetings to go ahead for some time, delegates met in London in late February for CAR-TCR.

Manufacture Advanced Medicine

Advanced Medicine: Replicating the mAb Success Story

| Stephanie Sutton

How can manufacturing be improved for viral vectors?

Business & Regulation Business Practice

One Vision, One Culture, One Team

| Rich Whitworth

Sitting Down With… Mike McMullen, President and CEO, Agilent Technologies, Santa Clara, California, USA.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register